The National Technical Advisory Group for Immunisation (NTAGI) has recommended introduction of The quadrivalent Human Papilloma Virus (qHPV) vaccine in the Universal Immunization Programme (UIP) with a one-time catch-up for 9-14 year-old adolescent girls followed with routine introduction
Three batches of approximately 80,000 doses of HPV vaccine have been released by Central drugs laboratory (CDL) in, Kasauli, Himachal Pradesh, sources said to ANI
Adar Poonawalla said that the availability of the Human Papillomavirus (HPV) vaccine will be little in number this year, however, it would be boosted next year.
New Delhi [India], October 21 (ANI): The production of India's first indigenously developed quadrivalent Human Papillomavirus (HPV) "CERVAVAC" vaccine, for the prevention of cervical cancer, by the Serum Institute of India will start in the first quarter of 2023 which got delayed due to C